Financials

Discussions Technicals Seasonals

URT fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Urteste SA specializes in the development of technology that allows the detection of cancers at early stages of their development. Its technology helps to detect cancers by measuring the activity of the enzymes in urine and also develops diagnostic tests for more than ten of the most common cancers. The company was founded on April 24, 2019 and is headquartered in Gdansk, Poland.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

URT does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company